Photopheresis: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tag: Reverted |
||
| Line 40: | Line 40: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Revision as of 22:56, 17 March 2025
Photopheresis is a type of apheresis and photodynamic therapy in which blood is treated with a photosensitizing agent and subsequently irradiated with specific wavelengths of light to treat a variety of disorders.
History
The technique was first introduced by Richard L. Edelson of Yale University in 1987 for the treatment of cutaneous T-cell lymphoma (CTCL). Since then, it has been used to treat a variety of other conditions.
Procedure
In photopheresis, the patient's blood is first drawn and separated into its components. The white blood cells are then mixed with a photosensitizing agent, usually methoxsalen, and exposed to ultraviolet A (UVA) light. The treated cells are then returned to the patient. The entire process takes about two to three hours and is usually performed on an outpatient basis.
Uses
Photopheresis has been used to treat a variety of conditions, including:
- Cutaneous T-cell lymphoma
- Graft-versus-host disease
- Systemic sclerosis
- Rheumatoid arthritis
- Crohn's disease
- Multiple sclerosis
- Type 1 diabetes
Side Effects
Possible side effects of photopheresis include:
See Also
References
<references />


